Two of the most profitable investments in the world can be commercial real estate and bio technology. While those two industries are very different from one another, one professional has developed a reputation for being a leader investor in both fields. This investor, Aaron Becker, recently shared his insights with the future of investing in both industries.
Aaron Becker was recently interviewed by the online magazine Idea Mensch. Becker spent much of the interview discussing the current state of the bio tech industry. He believes that there is a lot of potential for businesses to grow and expand due to the recent expansion of capital infusion. Becker stated that he is most excited about the status of some companies that have made a lot of strides in curing some diseases, including cancer. Becker further stated that while there is a lot of room for development in the field, there are still challenges due to competition, regulatory changes, and other outside factors that will influence the future of the industry.
While Becker has been an entreprenur for over a decade, he did previously have a long and successful career working for a number of top investment firms. Prior to going out on his own, Becker was the managing member for Madison Capital, an investment banking firm that specialized in providing capital to bio tech firms that are early in the development stages. In this role, he gained a strong appreciation for the potential investment returns that come with investing in bio tech.
Aaron Becker was also the CEO of two small companies, Zinio and NaviSite, each of which grew tremendously under his management. He even was involved when the latter company went from being private to publicly traded. While working in all of these roles, Becker spent some time learning the investment real estate industry and process and eventually purchased his own properties. https://www.linkedin.com/in/arthur-becker-1547a134